Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential

TSX:EDT - Post by User

Spectral Medical Inc > Vantive In Play

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Mar 05, 2024 9:52pm

103 Views

Post# 35917154

RE:RE:RE:RE:Vantive In Play

Thx Mac

Yes either the Vantive spin-off or the non-competitive divisional sell-off, will raise capital for two purposes :

1. debt reduction
2. take-overs of some higher margin businesses ( like say, idunno the NA rights to PMX)

If the sell-off becomes a more lucrative option than the spin-off option, then they will go for that and then there will be that much more money for objective #2

I'm pretty sure that this idea didnt just occur to Baxter in the 2 weeks since recommitting to Spectral and locking up the rights for longer.